Board approves Q1 FY27 results, auditor gives clean review

Results View source PDF Explain this filing

ONESOURCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.3%Reaction day

₹1649.00

prior close

₹1695.70

announcement price

After-mkt

timing

Nifty Smallcap 250market+1.3%+1.0% vs market

Pharmaceuticals peers, median of 165sector+0.7%+1.6% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Smallcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-3.0

15m

-2.9

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.3+1.3+1.0+0.7+1.6

Next day

+4.6+0.8+3.8+0.0+4.6

+6.1+2.1+4.0+1.0+5.1

+2.4+1.4+1.0+0.0+2.4

-1.8+1.8-3.6+0.1-1.8

-5.7+3.2-8.9+0.8-6.5

-6.6+4.1-10.7+1.0-7.6

15d

-6.3+4.0-10.3+1.7-8.1

-7.7+4.7-12.4+2.1-9.8

-5.1+1.5-6.6+2.3-7.4

-3.4-3.8+0.4-2.7-0.7

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Onesource Specialty Pharma board on July 24, 2026 approved unaudited standalone and consolidated financial results for Q1 FY27, quarter ended June 30, 2026. Auditor Deloitte Haskins and Sells issued an unmodified review report on both sets of results. Consolidated results cover 7 entities including 6 subsidiaries. Two subsidiaries reviewed by other auditors contributed about Rs 283.47 million in revenue and Rs 12.14 million net loss. Four unreviewed subsidiaries had nil revenue and Rs 1.79 million loss, deemed not material.

Likely market impact

Clean auditor review, standard quarterly results approval. No red flags in the auditor report. Detailed financials not included in this filing.